成都市女性体检人群骨密度调查  

Investigation on Bone Mineral Density of Female Physical Examination Population in Chengdu

作　　者：何礼霞[1] 何俊勇[1] 薛桂君[1] 曾莉[1] 唐怀蓉[1] 王佑娟[1] 

机构地区：[1]四川大学华西医院健康管理中心,四川成都610041

出　　处：《四川医学》2017年第7期724-726,共3页Sichuan Medical Journal

基　　金：四川省卫生厅项目(编号:120232)

摘　　要：目的了解成都市女性骨密度情况;骨质疏松的患病情况及年龄分布特点。方法选取2012年1月至2012年12月自愿到华西医院健康管理中心进行体检人群,采用超声骨密度仪测定体检者足跟的骨质状态。结果本研究共纳入研究对象3720例,35岁之后,骨密度逐渐下降,骨量减少和骨质疏松患病率(20.94%,2.09%)增加,50岁之后骨量丢失速度加快,骨量减少和骨质疏松患病率(38.15%,3.99%)呈明显增加趋势,70岁之后骨量减少和骨质疏松患病率患病率(50%,26.0%)最高,其间差异有统计学意义。随着高密度脂蛋白增高,骨密度呈下降趋势。年龄、高密度脂蛋白与骨密度负相关。结论随着年龄的增加,骨密度逐渐下降,随着绝经时间的延长,骨量丢失速度明显加快,骨质疏松的患病率增加。年龄、高密度脂蛋白是骨密度降低的危险因素。Objective To understand the condition of bone mineral density （BMD）and the prevalence and age distribu- tion features of osteoporosis of female population in Chengdu. Methods The crowd volunteered to West China Hospital Health Management Center for physical examination between January 2012 and December 2012were selected, and the ultrasonic bone den- sitometer was used to determine the bony status of the heel of the physical examination crowd. Results A total of 3720 cases were included in this study. After 35 years of age, bone mineral density decreased, and the prevalence of osteopenia and osteoporosis in- creased（20. 94% ,2. 09% ）. After 50 years of age, the rate of bone loss was accelerated, and the prevalence of osteopenia and oste- oporosis increased significantly（38.15% ,3.99% ）. After 70 years old,the prevalence rate of osteopenia and osteoporosis was the highest（ 50% ,26% ）, and the difference was statistically significant. With the increase of HI）L, the bone mineral density tended to decrease. Age and high density lipoprotein were negatively correlated with bone mineral density. Conclusion With the increase of age, bone mineral density decreases gradually. With the extension of menopause time, the speed of bone loss is significantly acceler- ated, and the prevalence of osteoporosis increases. Age and HDL are risk factors for bone mineral density reduction.

关 键 词：骨密度 骨质疏松 血脂 高密度脂蛋白 

分 类 号：R580[医药卫生—内分泌]